NCT04712305View on ClinicalTrials.gov

Urine Omics Predicting IO Therapy Responses in mRCC Patients

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

January 4, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Metastatic Renal Cell Carcinoma
Interventions
OTHER

No intervention required

No intervention required

Trial Locations (1)

100

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER